Your browser doesn't support javascript.
loading
The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin-transferrin receptor 1 axis.
Kameda, Kazuaki; Yanagiya, Ryo; Miyatake, Yuji; Carreras, Joaquim; Higuchi, Hiroshi; Murayama, Hiromichi; Ishida, Takashi; Ito, Asahi; Iida, Shinsuke; Fukuhara, Noriko; Harigae, Hideo; Fujioka, Yuki; Takahashi, Naoto; Wada, Hidenori; Ishida, Fumihiro; Nakazawa, Hideyuki; Ishihara, Rei; Murakami, Yuki; Tagawa, Hiroyuki; Matsuura, Tadashi; Nakagawa, So; Iwabuchi, Sadahiro; Hashimoto, Shinichi; Imadome, Ken-Ichi; Nakamura, Naoya; Ishizawa, Kenichi; Kanda, Yoshinobu; Ando, Kiyoshi; Kotani, Ai.
Affiliation
  • Kameda K; Department of Innovative Medical Science, Tokai University School of Medicine, Isehara, Japan.
  • Yanagiya R; Department of Hematological Malignancy, Institute of Medical Sciences, Tokai University, Isehara, Japan.
  • Miyatake Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
  • Carreras J; Department of Innovative Medical Science, Tokai University School of Medicine, Isehara, Japan.
  • Higuchi H; Department of Hematological Malignancy, Institute of Medical Sciences, Tokai University, Isehara, Japan.
  • Murayama H; Department of Neurology, Hematology, Diabetology, Endocrinology, and Metabolism (3rd Department of Internal Medicine), Faculty of Medicine, Yamagata University, Yamagata, Japan.
  • Ishida T; Department of Innovative Medical Science, Tokai University School of Medicine, Isehara, Japan.
  • Ito A; Department of Hematological Malignancy, Institute of Medical Sciences, Tokai University, Isehara, Japan.
  • Iida S; Department of Pathology, Tokai University School of Medicine, Isehara, Japan.
  • Fukuhara N; Department of Innovative Medical Science, Tokai University School of Medicine, Isehara, Japan.
  • Harigae H; Department of Hematological Malignancy, Institute of Medical Sciences, Tokai University, Isehara, Japan.
  • Fujioka Y; Department of Dermatology, Center for Cancer Immunology and Cutaneous Biology Research Center, Center for Cancer Research, Massachusetts General Hospital Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
  • Takahashi N; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
  • Wada H; Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Ishida F; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Nakazawa H; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Ishihara R; Department of Hematology, Tohoku University Hospital, Sendai, Japan.
  • Murakami Y; Department of Hematology, Tohoku University Hospital, Sendai, Japan.
  • Tagawa H; Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan.
  • Matsuura T; Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan.
  • Nakagawa S; Department of Hematology, Saitama Citizens Medical Center, Saitama, Japan.
  • Iwabuchi S; Department of Biomedical Laboratory Sciences, Shinshu University School of Medicine, Matsumoto, Japan.
  • Hashimoto S; Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
  • Imadome KI; Department of Laboratory Science, Gunma University Graduate School of Health Science, Maebashi, Japan.
  • Nakamura N; Department of Laboratory Science, Gunma University Graduate School of Health Science, Maebashi, Japan.
  • Ishizawa K; Department of Hematology, Hiraka General Hospital, Yokote, Japan.
  • Kanda Y; Perseus Proteomics, Inc, Tokyo, Japan.
  • Ando K; Department of Molecular Life Science, Tokai University School of Medicine, Isehara, Japan.
  • Kotani A; Department of Molecular Pathophysiology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama, Japan.
Blood ; 142(4): 352-364, 2023 07 27.
Article in En | MEDLINE | ID: mdl-37146246
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Prolymphocytic, T-Cell / Epstein-Barr Virus Infections / Leukemia, Large Granular Lymphocytic Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Blood Year: 2023 Document type: Article Affiliation country: Japan Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Prolymphocytic, T-Cell / Epstein-Barr Virus Infections / Leukemia, Large Granular Lymphocytic Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Blood Year: 2023 Document type: Article Affiliation country: Japan Country of publication: United States